Construction of ovine adenovirus recombinants by gene insertion or deletion of related terminal region sequences

Virology

Volumn 230, Issue 1, 1997, Pages 62-71

  Xu, Zheng Zhou ^a   Hyatt, Alex ^a   Boyle, David B ^a   Both, Gerald W ^a  

^a CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; GENE; GENE TRANSFER; MOLECULAR CLONING; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; OVIS; OVIS ARIES;

EID: 0031592574     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8452     Document Type: Article

References (52)

1. Ali M., Lemoine N. R., Ring C. J. A. The use of DNA viruses as vectors for gene therapy. Gene Ther. 1:1994;367-384.
2. Berkner K. L. Development of adenovirus vectors for the expression of heterologous genes. Biotechniques. 6:1988;616-629.
3. Bett A. J., Haddara W., Prevec L., Graham F. L. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA. 91:1994;8802-8806.
4. Bett A. J., Prevec L., Graham F. L. Packaging capacity and stability of human adenovirus type-5 vectors. J. Virol. 67:1993;5911-5921.
5. Both G. W., Lockett L. J., Janardhana V., Edwards S. J., Bellamy A. R., Graham F. L., Prevec L., Andrew M. E. Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc. Virology. 193:1993;940-950.
6. Boyle D. B., Pye A. D., Kockerhans R., Adair B. M., Vrati S., Both G. W. Characterisation of Australian ovine adenovirus isolates. Vet. Microbiol. 41:1994;281-291.
7. Caravokyri C., Leppard K. N. Constitutive episomal expression of polypeptide IX (pIX) in a 293-based cell line complements the deficiency of pIX mutant adenovirus type 5. J. Virol. 69:1995;6627-6633.
8. Chiocca S., Kurzbauer R., Schaffner G., Baker A., Mautner V., Cotten M. The complete DNA sequence and genomic organization of the avian adenovirus CELO. J. Virol. 70:1996;2939-2949.
9. Cladaras C., Wold W. S. The DNA sequence of the early E3 transcription unit of adenovirus type 5. Virology. 40:1985;28-43.
10. Crystal R. G., Mastrangeli A., Sanders A., Cooke J., King T., Gilbert F., Henschke C., Pascal W., Herena J., Harvey B. G., Hirschowitz E., Diaz D., Russi T., Pacheco F., Sikand V., Brion P. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis. Hum. Gene Ther. 6:1995;667-703.
11. Davison A. J., Telford E. A. R., Watson M. S., McBride K., Mautner V. The DNA sequence of adenovirus type-40. J. Mol. Biol. 234:1993;1308-1316.
12. DeMatteo R. P., Raper S. E., Ahn M., Fisher K. J., Burke C., Radu A., Widera G., Claytor B. R., Barker C. F., Markmann J. F. Gene transfer to the thymus: A means of abrogating the immune response to recombinant adenovirus. Ann. Surg. 222:1995;229-242.
13. Efrat S., Fejer G., Brownlee M., Horwitz M. S. Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes. Proc. Natl. Acad. Sci. USA. 92:1995;6947-6951.
14. Engelhardt J. F., Litzky L., Wilson J. M. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum. Gene Ther. 5:1994;1217-1229.
15. Fang B., Eisensmith R. C., Wang H., Kay M. A., Cross R. E., Landen C. N., Gordon G., Bellinger D. A., Read M. S., Hu P. C., Brinkhous K. M., Woo S. L. C. Gene therapy for hemophilia B: Host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Hum. Gene Ther. 6:1995;1039-1044.
16. Fisher K. J., Choi H., Burda J., Chen S. J., Wilson J. M. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology. 217:1996;11-22.
17. Fisher K. J., Wilson J. M. Biochemical and functional analysis of an adenovirus-based ligand complex for gene transfer. Biochem. J. 299:1994;49-58.
18. Gooding L. R. Virus proteins that counteract host immune defenses. Cell. 71:1992;5-7.
19. Graham F. L., Prevec L. Manipulation of adenovirus vectors. Methods in Molecular Biology. 1991;Humana Press, Clifton. p. 1-19.
20. Graham F. L., Prevec L. Adenovirus based expression vectors and recombinant vaccines. Elliss R. W. Vaccines: New Approaches to Immunological Problems. 1992;363-390 Butterworth-Heinemann, Stoneham.
21. Graham F. L., Smiley J., Russell W. C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:1977;59-72.
22. Harrach B., Meehan B. M., Benko M., Adair B. M., Todd D. Close phylogenetic relationship between egg drop syndrome virus, bovine adenovirus serotype 7 and ovine adenovirus strain 287. Virology. 1997.
23. Horwitz M. S. Adenoviruses. Fields B. N., Knipe D. M., Howley P. M. Fields Virology. 1996;2149-2171 Lippincott-Raven, Philadelphia.
24. Imler J. L., Chartier C., Dreyer D., Dieterle A., Saintemarie M., Faure T., Pavirani A., Mehtali M. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors. Gene Ther. 3:1996;75-84.
25. Johnson K. S., Harrison G. B. L., Lightowlers M. W., O'Hoy K. L., Cougle W. G., Dempster R. P., Lawrence S. B., Vinton J. G., Heath D. D., Rickard M. D. Vaccination against ovine cystericosis using a defined recombinant antigen. Nature. 338:1989;585-587.
26. Kochanek S., Clemens P. R., Mitani K., Chen H. H., Chan S., Caskey C. T. A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc. Natl. Acad. Sci. USA. 93:1996;5731-5736.
27. Lee M. G., Abina M. A., Haddada H., Perricaudet M. The constitutive expression of the immunomodulatory gp19k protein in E1(-), E3(-) adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector. Gene Ther. 2:1995;256-262.
28. Levrero M., Barban V., Manteca S., Ballay A., Balsamo C., Avantaggiati M. L., Natoli G., Skellekens H., Tiollais P., Perricaudet M. Defective and nondefective adenovirus vectors for expressing foreign genes in-vitro and in-vivo. GENE (Amst). 101:1991;195-202.
29. Mittal S. K., Prevec L., Babiuk L. A., Graham F. L. Sequence analysis of bovine adenovirus type-3 early region-3 and fibre protein genes. J. Gen. Virol. 73:1992;3295-3300.
30. Mittal S. K., Prevec L., Graham F. L., Babiuk L. A. Development of a bovine adenovirus type 3-based expression vector. J. Gen. Virol. 76:1995;93-102.
31. Morin J. E., Lubeck M. D., Barton J. E., Conley A. J., Davis A. R., Hung P. P. Recombinant adenovirus induces antibody responses to hepatitis B virus surface antigen in hamsters. Proc. Natl. Acad. Sci. USA. 84:1987;4626-4630.
32. Raviprakash K. S., Grunhaus A., El Kholy M. A., Horwitz M. S. The mouse adenovirus type 1 contains an unusual E3 region. J. Virol. 63:1989;5455-5458.
33. Rose R. E. The nucleotide sequence of pACYC184. Nucleic Acids Res. 16:1988;355.
34. Rosenfeld M. A., Yoshimura K., Trapnell B. C., Yoneyama K., Rosenthal E. R., Dalemans W., Fukayama M., Bargon J., Stier L. E., Stratford-Perricaudet L., Perricaudet M., Guggino W. B., Pavirani A., Lecocq J. P., Crystal R. G. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell. 68:1992;143-155.
35. Sene C., Bout A., Imler J. L., Schultz H., Willemot J. M., Hennebel V., Zurcher C., Valerio D., Lamy D., Pavirani A. Aerosol-mediated delivery of recombinant adenovirus to the airways of nonhuman primates. Hum. Gene Ther. 6:1995;1587-1593.
36. Smith A. E. Viral vectors in gene therapy. Annu. Rev. Microbiol. 49:1995;807-838.
37. Sprengel J., Schmitz B., Heussneitzel D., Zock C., Doerfler W. Nucleotide sequence of human adenovirus type 12 DNA-comparative functional analysis. J. Virol. 68:1994;379-389.
38. Stewart P. L., Burnett R. M., Cyrklaff M., Fuller S. D. Image reconstruction reveals the complex molecular organization of adenovirus. Cell. 67:1991;145-154.
39. Tollefson A. E., Scaria A., Hermiston T., Ryerse J. S., Wold L. J., Wold W. S. M. The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. J. Virol. 70:1996;2296-2306.
40. Vilquin J. T., Guerette B., Kinoshita I., Roy B., Goulet M., Gravel C., Roy R., Tremblay J. P. FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Hum. Gene Ther. 6:1995;1391-1401.
41. Vrati S., Boyle D. B., Kockerhans R., Both G. W. Sequence of ovine adenovirus 100k hexon assembly, 33k, pVIII and fiber genes: Early region E3 is not in the expected location. Virology. 209:1995;400-408.
42. Vrati S., Brookes D. B., Strike P., Khatri A., Boyle D. B., Both G. W. Unique genome arrangement of an ovine adenovirus: Identification of new proteins and proteinase cleavage sites. Virology. 220:1996a;186-199.
43. Vrati S., Brookes D. E., Boyle D. B., Both G. W. Nucleotide sequence of ovine adenovirus tripartite leader sequence and homologues of the IVa2, DNA polymerase and terminal proteins. Gene. 177:1996b;35-41.
44. Vrati S., MacAvoy E. S., Xu Z. Z., Smole C., Boyle D. B., Both G. W. Construction and transfection of ovine adenovirus genomic clones to rescue modified viruses. Virology. 220:1996c;200-203.
45. Wang Q., Jia X. C., Finer M. H. A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions. Gene Ther. 2:1995;775-783.
46. Wold W. S. M., Gooding L. R. Region E3 of adenovirus: A cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology. 184:1991;1-8.
47. Xu Z. Z., Krougliak V., Prevec L., Graham F. L., Both G. W. Investigation of promoter function in human and animal cells infected with human recombinant adenoviruses expressing rotavirus antigen VP7sc. J. Gen. Virol. 76:1995;1971-1980.
48. Yang Y. P., Li Q., Ertl H. C. J., Wilson J. M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:1995;2004-2015.
49. Yang Y. P., Nunes F. A., Berencsi K., Gonczol E., Engelhardt J. F., Wilson J. M. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat. Genet. 7:1994;362-369.
50. Yang Y. P., Trinchieri G., Wilson J. M. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Med. 1:1995;890-893.
51. Yang Y. P., Wilson J. M. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4(+) CTLs in vivo. J. Immunol. 155:1995;2564-2570.
52. Yeh P., Dedieu J. F., Orsini C., Vigne E., Denefle P., Perricaudet M. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J. Virol. 70:1996;559-565.